Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Seractide Acetate

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    ANI focuses on data insights to ramp up Cortrophin
    ANI focuses on data insights to ramp up Cortrophin

    24 Jun 2022

    // Karl Greenberg FIERCEPHARMA

    https://www.fiercepharma.com/marketing/ani-focuses-data-insights-ramp-its-arthritis-and-ms-flare-therapy

    Karl Greenberg FIERCEPHARMA
    24 Jun 2022
    Share Share
    U.S. sues Mallinckrodt, accuses drugmaker of defrauding Medicaid
    U.S. sues Mallinckrodt, accuses drugmaker of defrauding Medicaid

    04 Mar 2020

    // J. Stempel REUTERS

    https://in.reuters.com/article/us-usa-mallinckrodt-lawsuit/us-sues-mallinckrodt-accuses-drugmaker-of-defrauding-medicaid-idINKBN20Q2FV

    J. Stempel REUTERS
    04 Mar 2020
    Share Share
    Data on Acthar® Gel Therapy in Symptomatic Sarcoidosis Published
    Data on Acthar® Gel Therapy in Symptomatic Sarcoidosis Published

    26 Nov 2019

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/data-on-acthar-gel-repository-corticotropin-injection-therapy-in-symptomatic-sarcoidosis-published-in-therapeutic-advances-in-respiratory-disease-300965058.html

    PR NEWSWIRE
    26 Nov 2019
    Share Share
    Mallinckrodt receives SEC subpoena over Acthar gel lawsuit
    Mallinckrodt receives SEC subpoena over Acthar gel lawsuit

    07 Nov 2019

    // M.Maddipatla REUTER S

    https://www.reuters.com/article/us-mallinckrodt-lawsuit/mallinckrodt-receives-sec-subpoena-over-acthar-gel-lawsuit-idUSKBN1XF2QR?feedType=RSS&feedName=healthNews

    M.Maddipatla REUTER S
    07 Nov 2019
    Share Share
    Mallinckrodt unloads its CDMO for $250M as potential liabilities mount
    Mallinckrodt unloads its CDMO for $250M as potential liabilities mount

    10 Sep 2019

    // Eric Palmer FIERCE PHARMA

    https://www.fiercepharma.com/manufacturing/mallinckrodt-unloads-its-cdmo-for-250m-as-liabilities-mushroom

    Eric Palmer FIERCE PHARMA
    10 Sep 2019
    Share Share
    Mallinckrodt investors stream for the exits as opioid-tied bankruptcy talk mount
    Mallinckrodt investors stream for the exits as opioid-tied bankruptcy talk mount

    07 Sep 2019

    // K. Blankenship FIERCEPHARMA

    https://www.fiercepharma.com/pharma/mallinckrodt-investors-stream-for-exits-as-opioid-tied-bankruptcy-talk-mounts

    K. Blankenship FIERCEPHARMA
    07 Sep 2019
    Share Share